Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Glutaminase inhibition (GLSi) has promising activity against certain cancers. Here, the authors show that GLSi has no effect on multiple mouse models of pancreatic cancer and characterize the metabolic pathways activated in response to GLSi whose concomitant inhibition may have therapeutic utility.
Guardado en:
Autores principales: | Douglas E. Biancur, Joao A. Paulo, Beata Małachowska, Maria Quiles Del Rey, Cristovão M. Sousa, Xiaoxu Wang, Albert S. W. Sohn, Gerald C. Chu, Steven P. Gygi, J. Wade Harper, Wojciech Fendler, Joseph D. Mancias, Alec C. Kimmelman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c1c97f9f96f44b8b385caffd639b374 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting glutamine metabolism slows soft tissue sarcoma growth
por: Pearl Lee, et al.
Publicado: (2020) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
por: Leal Oburoglu, et al.
Publicado: (2021) -
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
por: Manabu Kodama, et al.
Publicado: (2020) -
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Ru Chen, et al.
Publicado: (2017) -
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
por: Yuanyuan Wang, et al.
Publicado: (2019)